Glenmark Pharmaceuticals shares tumble nearly 6% over alleged false claims about ‘FabiFlu’
New Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals announced Tuesday that it will commence another new Phase 3 clinical trial. This will be on ...
Read moreDetails
The Supreme Court stating on 5 October that it has not approved any modifications to Form 6 being used by...
Read moreDetailsIndia’s air-power shortcomings are becoming harder to ignore. Air Chief Marshal AP Singh, very publicly, flagging Pakistan’s collaboration with China...
Read moreDetailsBy Aakar Patel While Gandhi Jayanti is still fresh on our minds and the right to peaceful assembly is in...
Read moreDetailsBy Dilip Cherian A 10-officer reshuffle at the Additional Secretary level may look like routine housekeeping, but if you look...
Read moreDetails
